![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 4, 2227-2235, 02, 1984
ML Toews and JP Perkins
Competition by beta-adrenergic agonists and antagonists for 125I- pindolol
binding sites on intact cells (1321N1 human astrocytoma and C62B rat
glioma) was measured using short time binding assays as previously
described (Toews, M. L., Harden, T. K., and Perkins, J. P. (1983) Proc.
Natl. Acad. Sci. U.S.A. 80, 3553-3557). Preincubation of cells with
agonists converted about half of the cellular beta- adrenergic receptors
from a form exhibiting high affinity for the agonists isoproterenol and
epinephrine and the antagonist sotalol to a form exhibiting much lower
apparent affinity for these ligands in short time assays. Exposure to
agonists did not alter the affinity of receptors for the antagonist
metoprolol. This change in the ligand binding properties of the receptor
was rapid (t1/2 = 1-2 min following a lag of about 0.5 min), reversible
(t1/2 = 6-8 min), and dependent on the agonist concentration present during
the preincubation (K0.5 = 15 nM for isoproterenol). Both isoproterenol and
sotalol attained equilibrium with the high affinity receptors very rapidly
but equilibrated only slowly with those receptors exhibiting low apparent
affinity in short time assays. These results are interpreted in terms of a
model which postulates that both the low apparent affinity in short time
assays and the subsequent slow equilibration of hydrophilic ligands with
these receptors result from agonist-induced internalization of a fraction
of cell surface beta-adrenergic receptors. The relationship of this change
in receptor binding properties to other aspects of agonist-induced
desensitization of the beta-adrenergic receptor-coupled adenylate cyclase
system is discussed.
Agonist-induced changes in beta-adrenergic receptors on intact cells
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Thielemans, I. Depoortere, J. Perret, P. Robberecht, Y. Liu, T. Thijs, C. Carreras, E. Burgeon, and T. L. Peeters Desensitization of the Human Motilin Receptor by Motilides J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1397 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Avlani, L. T. May, P. M. Sexton, and A. Christopoulos Application of a Kinetic Model to the Apparently Complex Behavior of Negative and Positive Allosteric Modulators of Muscarinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1062 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Zaki, D. E. Keith Jr., G. A. Brine, F. I. Carroll, and C. J. Evans Ligand-Induced Changes in Surface {micro}-Opioid Receptor Number: Relationship to G Protein Activation? J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1127 - 1134. [Abstract] [Full Text] |
||||
![]() |
B. January, A. Seibold, B. Whaley, R. W. Hipkin, D. Lin, A. Schonbrunn, R. Barber, and R. B. Clark beta 2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists J. Biol. Chem., September 19, 1997; 272(38): 23871 - 23879. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Leiros, L. Sterin-Borda, E. S Borda, J. C. Goin, and M. M. Hosey Desensitization and Sequestration of Human m2 Muscarinic Acetylcholine Receptors by Autoantibodies from Patients with Chagas' Disease J. Biol. Chem., May 16, 1997; 272(20): 12989 - 12993. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |